Does third-generation TAVI provide similar device success and complication rates in patients with extra-large aortic annulus compared to those with regular-sized annulus?
Third-generation TAVI is feasible and safe in patients with extra-large aortic annuli, though moderate paravalvular leak remains a clinical concern.
Treatment of ELA patients with third-generation TAVI prostheses is feasible and safe, providing similar device success and complication rates as in matched controls with regular-sized aortic annulus. Post-interventional pacemaker implantation rates were low compared to the control group, yet incidence of moderate PVL remains problematic in ELA patients.
Hof et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: